Differently, METTL14 decreases GPX4 mRNA stability through a YTHDF2-dependent mechanism, increases lipid peroxidation levels, and accelerates iron death in endometrial cancer, and thereby inhibits tumor progression (Wang et al., 2023[278]). The gene discussed is METTL14; the disease is neoplasm.